REVATHY B IYER to Radiopharmaceuticals
This is a "connection" page, showing publications REVATHY B IYER has written about Radiopharmaceuticals.
Connection Strength
0.378
-
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50.
Score: 0.075
-
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44.
Score: 0.063
-
Adrenal pheochromocytoma with surrounding brown fat stimulation. AJR Am J Roentgenol. 2009 Jan; 192(1):300-1.
Score: 0.056
-
Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. AJR Am J Roentgenol. 2008 Nov; 191(5):1545-51.
Score: 0.056
-
PET/CT and hepatic radiation injury in esophageal cancer patients. Cancer Imaging. 2007 Nov 26; 7:189-94.
Score: 0.052
-
PET/CT and cross sectional imaging of gynecologic malignancy. Cancer Imaging. 2007 Oct 01; 7 Spec No A:S130-8.
Score: 0.052
-
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer. 2010 Mar 15; 116(6):1454-61.
Score: 0.015
-
The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004 Jan; 45(1):17-21.
Score: 0.010